Insider Transactions in Q2 2022 at Pfizer Inc (PFE)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 07
2022
|
Jennifer B. Damico SVP & Controller |
SELL
Open market or private sale
|
Direct |
4,218
-28.0%
|
$223,554
$53.96 P/Share
|
|
May 31
2022
|
David M Denton Chief Financial Officer & EVP |
BUY
Grant, award, or other acquisition
|
Direct |
61,275
+49.64%
|
-
|
|
May 16
2022
|
Jennifer B. Damico SVP & Controller |
SELL
Open market or private sale
|
Direct |
4,000
-20.98%
|
$200,000
$50.5 P/Share
|
|
May 13
2022
|
Payal Sahni Executive Vice President |
SELL
Open market or private sale
|
Direct |
1,408
-7.5%
|
$68,992
$49.84 P/Share
|
|
May 12
2022
|
Douglas M Lankler Executive Vice President |
SELL
Open market or private sale
|
Direct |
38,273
-32.69%
|
$1,875,377
$49.41 P/Share
|
|
May 12
2022
|
William R Carapezzi Jr Executive Vice President |
SELL
Open market or private sale
|
Direct |
32,908
-46.31%
|
$1,645,400
$50.0 P/Share
|
|
May 11
2022
|
Sally Susman Executive Vice President |
SELL
Bona fide gift
|
Direct |
5,000
-4.02%
|
-
|
|
May 11
2022
|
Mikael Dolsten President R&D |
SELL
Open market or private sale
|
Direct |
63,902
-2.83%
|
$3,131,198
$49.34 P/Share
|